These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24814404)

  • 1. Prognostic effect of serum and tissue YKL-40 levels in bladder cancer.
    Tschirdewahn S; Reis H; Niedworok C; Nyirady P; Szendröi A; Schmid KW; Shariat SF; Kramer G; vom Dorp F; Rübben H; Szarvas T
    Urol Oncol; 2014 Jul; 32(5):663-9. PubMed ID: 24814404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
    Zhu CB; Chen LL; Tian JJ; Su L; Wang C; Gai ZT; Du WJ; Ma GL
    Ann Surg Oncol; 2012 Mar; 19(3):817-25. PubMed ID: 21861215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
    Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
    Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer.
    Vom Dorp F; Tschirdewahn S; Niedworok C; Reis H; Krause H; Kempkensteffen C; Busch J; Kramer G; Shariat SF; Nyirady P; Rübben H; Szarvas T
    J Urol; 2016 Apr; 195(4 Pt 1):1120-5. PubMed ID: 26454102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhage.
    Jiang YX; Zhang GH; Wang ZM; Yang H
    Clin Biochem; 2014 Dec; 47(18):302-6. PubMed ID: 25262987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis.
    Richter B; Roslind A; Hesse U; Nordling J; Johansen JS; Horn T; Hansen AB
    Histopathology; 2010 Sep; 57(3):371-83. PubMed ID: 20840668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
    Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
    Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
    Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
    Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer.
    Kemik P; Saatli B; Yıldırım N; Kemik VD; Deveci B; Terek MC; Koçtürk S; Koyuncuoğlu M; Saygılı U
    Gynecol Oncol; 2016 Jan; 140(1):64-9. PubMed ID: 26607777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
    Jaksch P; Taghavi S; Klepetko W; Salama M
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer.
    Yamac D; Ozturk B; Coskun U; Tekin E; Sancak B; Yildiz R; Atalay C
    Adv Ther; 2008 Aug; 25(8):801-9. PubMed ID: 18670741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic and prognostic value of serum YKL-40 in endometrial cancer.
    Fan JT; Si XH; Liao Y; Shen P
    Arch Gynecol Obstet; 2013 Jan; 287(1):111-5. PubMed ID: 22945838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer.
    Kim SH; Das K; Noreen S; Coffman F; Hameed M
    World J Surg Oncol; 2007 Feb; 5():17. PubMed ID: 17286869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts.
    Kornblit B; Hellemann D; Munthe-Fog L; Bonde J; Strøm JJ; Madsen HO; Johansen JS; Garred P
    Immunobiology; 2013 Oct; 218(10):1227-34. PubMed ID: 23706599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure.
    Bilim O; Takeishi Y; Kitahara T; Ishino M; Sasaki T; Suzuki S; Shishido T; Kubota I
    J Card Fail; 2010 Nov; 16(11):873-9. PubMed ID: 21055651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin-leptin network influences serum chitinase 3-like protein 1 (YKL-40) levels in obese prepubertal children.
    Kyrgios I; Galli-Tsinopoulou A; Stylianou C
    Regul Pept; 2013 May; 183():69-73. PubMed ID: 23501042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.
    Diefenbach CS; Shah Z; Iasonos A; Barakat RR; Levine DA; Aghajanian C; Sabbatini P; Hensley ML; Konner J; Tew W; Spriggs D; Fleisher M; Thaler H; Dupont J
    Gynecol Oncol; 2007 Feb; 104(2):435-42. PubMed ID: 17023034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
    Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
    Cancer; 2002 Jul; 95(2):267-74. PubMed ID: 12124825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of YKL-40 expression by corticosteroids: effect on pro-inflammatory macrophages in vitro and its modulation in COPD in vivo.
    Kunz LI; van't Wout EF; van Schadewijk A; Postma DS; Kerstjens HA; Sterk PJ; Hiemstra PS
    Respir Res; 2015 Dec; 16():154. PubMed ID: 26696093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer.
    Szarvas T; Reis H; Kramer G; Shariat SF; Vom Dorp F; Tschirdewahn S; Schmid KW; Kovalszky I; Rübben H
    Hum Pathol; 2014 Apr; 45(4):674-82. PubMed ID: 24656090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.